跳至主要内容
临床试验/CTRI/2023/09/058165
CTRI/2023/09/058165尚未招募Unknown

To study the safety and efficacy of Panchakarma Essential (Katibasti) in the management of lowerback pain. - Nil

Mprex Healthcare Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male and female subjects 30-60 years of age (both inclusive)2.Subject has a confirmed diagnosis of lower back pain for a minimum of 3 months.3.Subject having Oswestry low back pain disability score below 80%.4.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures

排除标准

  • 1.Female patients having pregnancy or post-delivery period. 2.Subjects having lower back pain due to osteoporosis, especially having excessive distention of the abdomen due to obesity, and bone cancer. 3. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

研究者

相似试验